![Catherine Adams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Adams
Directeur Général chez
ACADIA PHARMACEUTICALS INC.
Fortune : 640 064 $ au 31/05/2026
Profil
Catherine Owen Adams currently works at ACADIA Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2024, Agios Pharmaceuticals, Inc., as Independent Director from 2023, AssistRx, Inc., as Directors from 2024, OptiNose US, Inc., as Director from 2020, Royal Pharmaceutical Society, as Member, The Chartered Institute of Marketing, as Member, and Healthcare Businesswomens Association, as Member from 2019.
Ms. Adams also formerly worked at OptiNose, Inc., as Independent Director from 2020 to 2024, Johnson & Johnson, as President-Janssen Immunology North America from 2018 to 2019, Janssen BioPharma LLC, as President-Immunology, Bristol-Myers Squibb Pharma Co., as Senior VP & General Manager-US Commercialization, and Robert Wood Johnson University Hospital Somerset, as Trustee.
Ms. Adams received her undergraduate degree from The University of Manchester.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/03/2026 | 14 803 ( 0,01 % ) | 320 633 $ | 31/05/2026 | |
| 18/06/2026 | 10 865 ( 0,02 % ) | 319 431 $ | 31/05/2026 |
Postes actifs de Catherine Adams
| Sociétés | Poste | Début |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 13/06/2023 |
| ACADIA PHARMACEUTICALS INC. | Directeur Général | 20/09/2024 |
Royal Pharmaceutical Society
 Royal Pharmaceutical Society Miscellaneous Commercial ServicesCommercial Services Operates as professional membership body for pharmacists and pharmacy | Corporate Officer/Principal | - |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Operates women healthcare associations | Corporate Officer/Principal | 01/01/2019 |
OptiNose US, Inc.
 OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company which develops breath powered nasal technology | Directeur/Membre du Conseil | 01/07/2020 |
The Chartered Institute of Marketing
 The Chartered Institute of Marketing Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
AssistRx, Inc.
 AssistRx, Inc. Packaged SoftwareTechnology Services Operates as a platform for healthcare providers that simplifies the process of getting patients access to medications and crucial patient support programs | Directeur/Membre du Conseil | 01/07/2024 |
Anciens postes connus de Catherine Adams
| Sociétés | Poste | Fin |
|---|---|---|
| OPTINOSE, INC. | Directeur/Membre du Conseil | 24/09/2024 |
Bristol-Myers Squibb Pharma Co. | Corporate Officer/Principal | 01/04/2024 |
| ░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Catherine Adams
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Healthcare Businesswomens Association
Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Operates women healthcare associations | Commercial Services |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chartered Institute of Marketing
The Chartered Institute of Marketing Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Pharma Co. | |
OptiNose US, Inc.
OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company which develops breath powered nasal technology | Health Technology |
AssistRx, Inc.
AssistRx, Inc. Packaged SoftwareTechnology Services Operates as a platform for healthcare providers that simplifies the process of getting patients access to medications and crucial patient support programs | Technology Services |
Royal Pharmaceutical Society
Royal Pharmaceutical Society Miscellaneous Commercial ServicesCommercial Services Operates as professional membership body for pharmacists and pharmacy | Commercial Services |
Janssen BioPharma LLC | |
Robert Wood Johnson University Hospital Somerset
 Robert Wood Johnson University Hospital Somerset Hospital/Nursing ManagementHealth Services Robert Wood Johnson University Hospital Somerset is a comprehensive community hospital that offers a wide range of specialty services including cancer care, cardiovascular and stroke care, orthopedics, neuroscience, mental and behavioral health, senior health, weight loss and bariatric surgery, maternity services, and pediatrics. The private company is based in Somerville, NJ. The hospital features advanced facilities such as the Steeplechase Cancer Center, which provides multidisciplinary cancer treatment and access to clinical trials, and the Babs Siperstein PROUD Center, dedicated to primary care for LGBTQ+ adults. Recent expansions include a consolidated cardiology floor and an upcoming inpatient orthopedic and post-surgical unit. The hospital emphasizes patient-centered care, accessibility, and community health through resources, educational programs, support groups, and outreach initiatives. The company was founded in 1899. The CEO is Bill Arnold. | Health Services |
Choisissez Zonebourse 
